Metoclopramid Slavia

Metoclopramide, the active ingredient in Metoclopramid Slavia, is a dopamine antagonist (antiemetic, gastro‑prokinetic) presented as an oral tablet for oral use. It treats nausea, vomiting and gastric motility disorders in adults.

GNH USA supplies Metoclopramid Slavia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramid Slavia acts on dopaminergic pathways to control emesis and improve gastrointestinal motility.

- Nausea and vomiting (including postoperative and chemotherapy‑induced): reduces the frequency and severity of episodes. - Gastroparesis: accelerates gastric emptying and relieves associated symptoms. - Gastro‑oesophageal reflux disease (GERD) adjunct therapy: enhances reflux symptom control when used with standard treatment.

Metoclopramid Slavia may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: mild sedation or sleepiness. - Fatigue: general feeling of tiredness. - Restlessness: inner sense of agitation. - Diarrhea: loose stools. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Extrapyramidal symptoms (e.g., dystonia, akathisia): involuntary muscle movements. - Tardive dyskinesia: persistent involuntary facial movements. - Neuroleptic malignant syndrome: life‑threatening hyperthermia and rigidity. - Severe depression or suicidal thoughts. - Seizures: convulsive episodes. - Cardiac arrhythmia: irregular heart rhythm.

Before prescribing Metoclopramid Slavia, clinicians should consider several safety measures.

- Assess renal function: adjust use in severe impairment. - Review medication history: avoid concurrent dopamine antagonists. - Monitor for extrapyramidal signs: report any involuntary movements promptly. - Use caution in patients with depression or Parkinson's disease: may exacerbate symptoms. - Avoid in children unless specifically indicated: higher risk of tardive dyskinesia. - Store at below 25°C: keep in the original pack, protect from moisture.

Metoclopramid Slavia can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive dopamine blockade. - MAO inhibitors: risk of hypertensive crisis. - CNS depressants (opioids, benzodiazepines): increased sedation. - CYP2D6 inhibitors (e.g., fluoxetine): elevated metoclopramide levels. - QT‑prolonging agents: heightened arrhythmia risk.

Moderate Interactions (Monitor Closely): - Anticholinergics: may reduce pro‑kinetic effect. - SSRIs: potential additive serotonergic activity. - Diuretics: possible enhancement of hypotension. - Alcohol: increased drowsiness. - Herbal supplements (e.g., St. John’s wort): possible enzyme induction affecting plasma concentrations.